Skip to main content
. 2013 Oct 29;32(23):3055–3065. doi: 10.1038/emboj.2013.232

Figure 4.

Figure 4

Antiviral effect of recombinant human Interferon lambda 4 against hepatitis C virus. (A, B) The antiviral effect of IFNα (A), IFNλ3 or IFNλ4 (B) against replication of the HCV JcR-2a chimaera in the Huh7-Lunet N hCD81-FLuc cell line is shown. (C, D) The antiviral effect of IFNα (C), IFNλ3 or IFNλ4 (D) against replication of the HCV JcR-2a chimaera in the HepG2 cell line is shown. The plot shows the average of three independent experiments with the Renilla luciferase activity normalised to the untreated control. Background luciferase activity is 0.2% for (A, B) and 2.4% for (C, D).